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Abstract 
Background: Many researchers have studied the relationship between diet and health. 
Specifically, there are papers showing an association between the consumption of sugar-
sweetened beverages and Type 2 diabetes. Many meta-analyses use individual (primary) studies 
that don’t adjust for multiple testing or multiple modeling – and thus provide biased estimates of 
effect.  Hence the claims reported in a meta-analysis paper may be unreliable if the primary 
papers do not ensure unbiased estimates of effect.  
Objective: Determine (i) the statistical reliability of 10 papers and (ii) indirectly the reliability of 
the meta-analysis study.  
Method: We obtained copies of each of the 10 primary papers used in a meta-analysis paper and 
counted the numbers of outcomes, predictors, and covariates. We estimated the size of the 
potential analysis search space available to the authors of these papers; i.e. the number of 
comparisons and models available. The potential analysis search space is the number of 
outcomes times the number of predictors times 2c, where c is the number of covariates.  Since we 
noticed that there were differences between predictors and covariates cited in the abstract and in 
the text, we applied this formula to information found in the abstracts, Space A, as well as the 
text, Space T, of each primary paper.  
 
Results: The median and range of the number of comparisons possible across the primary papers 
are 6.5 and (2 - 12,288), respectively for the abstracts, and 196,608 and (3,072 -117,117,952), 
respectively for the texts. Note that the median of 6.5 for Space A is misleading as each primary 
study has 60-165 foods not mentioned in the abstract.  
Conclusion: Given that testing is at the 5% level and the number of comparisons is very large, 
nominal statistical significance is very weak support for a claim. The claims in these papers are 
not statistically supported and hence are unreliable. Thus, the claims of the meta-analysis paper 
lack evidentiary confirmation. 
 
Key words: observational studies, nutritional epidemiology, reliability of claims, multiple 
testing, multiple modeling, meta-analysis. 
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1.0 Summary of logic of this paper 
Often a paper is presented as a story where certain items are highlighted; items that do 
not fit the story are sometimes omitted; the reader must wait to the end to see how it all turns out. 
Here the items are too complex for a simple story so we outline the internal logic of our study to 
assist the reader. The paper fills in details and offers justifications.  
First, claims coming from observational studies most often do not replicate. Second, 
using simple counting, we determine search spaces, the number of questions at issue, in the ten 
primary papers used in a meta-analysis study. Multiple testing and multiple modeling, MTMM, 
are well-known problems of observational studies that can produce small (invalid) p-values. 
Although MTMM are well-understood, in practice they are often ignored. Next, we note that if a 
false positive p-value is used to claim an effect, it derives from a biased estimate of a treatment 
effect. Finally, a fundamental requirement of a meta-analysis is unbiased estimates of effect from 
the primary studies. Multiple testing and multiple modeling produce false, small p-values and 
biased estimates of treatment effects, which in turn make the meta-analysis unreliable/invalid.  
2.0 Reliability of observational studies 
2.1 Observational Studies 
Epidemiology exhibits a notoriously poor record of reproducibility of published findings 
going back at least as far as Feinstein (4) and Mayes et al. (5); they found papers on both sides of 
the questions which were current at that time. There are continuing complaints about the 
reliability of observational studies: Taubes and Mann (6), Ioannidis (7), Kaplan et al. (8), Young 
and Karr (9), and Breslow (10, 11) to name a few.   Breslow commented that “contradictory 
results emanating from a plethora of irreproducible observational studies have contributed to 
the lack of esteem with which epidemiology is regarded by many in the wider biomedical 
community.” Even the popular press is speaking up; Taubes (12) and Hughes (13) are two 
examples. See also Wikipedia (14)  Replication crisis. Ominously, there may be actual misuse 
and/or even deliberate abuse of model fitting methods; see Glaeser (15), Young and Karr (9). 
Two groups of researchers using the same observational data base found that a treatment both 
caused, Cardwell et al. (16), and did not cause, Green et al. (17), cancer of the esophagus. 
Recently Schoenfeld and Ioannidis (18) found similar problems with nutritional studies, a review 
of ingredients in a cookbook.  
The state of published scientific claims is sufficiently suspect that a consumer should 
start with the presumption that any claim made is as likely as not to be wrong (it will fail to 
replicate) and any treatment effect is likely biased. False positive p-values and biased estimates 
of treatment effects come in pairs. 
 
2.2 The nature of a meta-analysis 
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In a meta-analysis, an effect estimate (statistic), e.g. a mean, a ratio, etc., is taken from 
each primary paper and combined, e.g. average, weighted average, to give a better measure of 
some finding, Chen and Peace (1) and Ehm (2). Key requirements of the statistics (measures of 
effects) coming from primary papers used in a meta-analysis are that the statistics are  
independent and unbiased, Boos and Stefanski (3). For a meta-analysis of randomized studies, 
these conditions are usually met; the papers are independent and randomization gives unbiased 
estimates. There still may be bias, e.g. non-adherence.   
 In randomized clinical trials (RCTs), very careful attention is given to the statistical 
analysis. A protocol, with a statistical analysis section (SAS) and a statistical analysis plan 
(SAP), is developed and agreed to by the interested parties, often a drug company and the FDA, 
before the study starts. One of the major concerns is the control of false positive results - a biased 
answer, which can be accomplished by using methods that preserve the overall experiment-wise 
error or false positive rate at a level of 5% or smaller.  
 Contrast the typical nutritional, Food Frequency Questionnaire, FFQ, observational study 
with a RCT. Each food is analyzed separately and sometimes in combinations. Multiple 
outcomes can be examined and the multiple food variables can be used as predictors. The 
analysis can be adjusted by putting multiple covariates into and out of the model, e.g. age, 
gender. There is usually no written protocol. For these factors (outcomes, predictors, covariates), 
there is no standard analysis strategy. The improvised strategy is often try-this-and-try-that. 
Under these circumstances, the analysis is essentially exploratory and the validity of 
claims/conclusions need further investigation.  
2.3 Our thesis 
Our thesis is that these FFQ papers are essentially exploratory - not confirmatory. In an 
exploratory study, typically many questions are at issue and analysis methods can be modified to 
meet the situation; in a confirmatory study, the entire study process is specified in a protocol, the 
outcome and predictor are specified, and statistical error is controlled, etc. In addition, there may 
be publication bias, negative studies are either not reported or they are rejected by editors and 
referees. 
A major contribution of this research is to show that the analysis strategy used in the 10 
primary papers produce biased statistics, which are unsuitable for inclusion in a meta-analysis 
study. Again, the potential for multiple testing and multiple modeling to bias results is well-
known, but this problem is typically ignored in FFQ studies. 
 
3.0 Data 
Malik (19) with a meta-analysis looks at sugar-sweetened beverages and the risk of 
metabolic syndrome and type 2 diabetes, hereafter referred to as Malik. We examine the 10 
primary papers (20-29) upon which the meta-analysis is based.  
 
4. Methods 
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4.1   Operation 
A protocol and data extraction form (DEF) were developed (Appendix) and the methods 
therein followed. Two teams were formed, each consisting of an Assistant Professor, a DrPH 
student and a Master's level student of Biostatistics.  Membership of the teams was determined 
randomly. The 10 primary papers were randomly assigned in a balanced fashion to the two 
teams.  Each team carefully reviewed the assigned 5 papers, extracted data therefrom in period 1 
and filled in the DEF. The 5 papers reviewed by Team 1 were then crossed over to Team 2 for 
review and data extraction and vice versa. Differences in extraction results from the DEF 
between the two teams were resolved by the Co-PIs. A final DEF was completed for each paper. 
All final DEFs were posted to the study folder on the Google drive in PDF format. All final 
DEFs are available as supplemental material. 
 
4.2 Screening and Evaluation  
We read the meta-analysis and primary papers, filled in the data extraction form (DEF), 
and requested raw data from the lead author of each primary paper. Data extracted were: sample 
sizes, p-values, relative risks, confidence limits outcomes, predictors, covariates and funding 
sources. The counting of covariates is difficult as they can appear throughout the paper. Also, the 
number of potential covariates might be larger than the count as some are not mentioned in the 
paper. 
Functions of these counts were used to estimate the potential size of the analysis search 
space available to the researcher; i.e. the number of comparisons and models available. The 
potential analysis search space for each primary paper was computed as the number of outcomes 
times the number of predictors times 2c, where c is the number of covariates.  This formula was 
applied to information found in both the abstract (Space A) as well as the text (Space T) of each 
primary paper. 
 
5.0 RESULTS  
Across the 10 studies (Table 1), sample sizes ranged from 4,304 to 91,249, with a median 
of 28,897 and a total of 332,357; smallest nominal P-Values ranged from 0.0001-0.001; and 
largest reported relative risk (RR) ranged from 1.23 – 5.06 with a median of 2.07. Eighty percent 
(80%) of the studies reported only government funding, 10% reported both government and non-
government funding and 10% was unfunded.  
 The number of outcomes, predictors, and covariates for each of the 10 primary papers 
appear in Table 2. The range and median of the number of comparisons possible across the 
primary papers are (2 - 12,288) and 6.5, respectively for Space A (Table 3), and (3,072 - 
117,117,952) and 196,608, respectively for Space T (Table 4). None of the 10 papers mention 
correcting for multiple testing or multiple modeling. There is no evidence of adjusting for 
multiplicities of any kind. All papers appear to test at the 5% level.  
As it is impossible to “prove a negative,” it is the responsibility of a researcher making a 
claim to provide strong evidence in support of the presumed positive claim. Given the multiple 
testing and multiple modeling, none of these papers provide strong evidence for their claims. 
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Any claim made could easily be a false positive. Note that each of the 10 primary papers should 
be examined separately for the validity of inferences. They must stand on their own before they 
can be considered for combining in a meta-analysis. As the statistics used in the primary papers 
do not provide valid evidence for the claim, the validity of the claim from the meta-analysis 
paper is questionable. 
 
Expected order statistics and corresponding p-values 
 
It is useful to review order statistics, their expected values and their relation to expected p-values 
as a function of the number of observations in a sample. If a random sample is taken from a 
population, and the objects are ordered from smallest to largest, the reordered objects are called 
order statistics. The value of the largest order statistic in the sample does not change from its 
value in the unordered sample, but it is different. It is the largest number in the sample. The 
larger the sample, the larger is the expected value of the largest object (see Table 5). Consider a 
sample from the normal distribution with a mean of zero and a standard deviation of one. If there 
are 10 objects in the sample, then the expected value of the largest object is 1.54.  
 
Besides the expected value, the p-value for a z-test against the value zero is given. We expect the 
largest value in a sample of 10 to be about 0.5 standard deviations above the mean.  Now look 
down Table 5. As sample size (N) increases, the expected value of the largest order statistic 
increases. In a sample of 30, we expect the largest order statistic, by chance alone, to be about 
2.04 standard deviations larger than the mean (of zero). The corresponding (unadjusted) p-value 
is 0.0495, which would be nominally statistically significant. 
 
As the numerical value of the largest order statistic is the same as its value in the sample, the fact 
that it is an order statistic is often overlooked, which we consider a grave mistake as it is biased; 
i.e. its expected value is not zero. It is wrong to consider the largest order statistic as if it were a 
random observation! It is common to adjust p-values when there are many questions at issue to 
control the false positive error rate. This Table can be used to remind a researcher that the value 
of an object can be large by chance alone and that a p-value can be small, again by chance alone. 
The larger the sample, the larger will be the value of the largest order statistic and the smaller 
will be the p-value.  
 
If, after adjustment, a p-value is not statistically significant, the researcher needs to keep in mind 
that the corresponding experimental value is an order statistic and needs to be judged by 
expected values of order statistics, not as if it were a random value from the distribution in 
question.  
 
The researcher can “cut” a continuous distribution to create ordered groups. The low group can 
be used as a reference group and the other groups can be compared to the reference group. The 
set of groups can be tested for linear trend. In Table 7, the number of p-values displayed in each 
paper is given as #Tests. 
______________________________________________________________________________ 
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To make things concrete, suppose that there are 60 questions at issue in a study, and to 
simplify this discussion, assume the questions are independent of one another, then by chance 
alone we would expect to see a mean value of 2.31 standard deviations and a p-value of 0.027 for 
the largest order statistic. Without taking order statistics and multiple testing into account, we 
would declare statistical significance AND we would not expect the result to replicate. We 
would have a false positive. Taking the value of 2.31 to a meta-analysis would bias the meta-
analysis and therefore would be misleading. The classic reference for computing the expected 
value of order statistics is Royston (30) who also quotes a well-known formula by Blom (31). 
 
Statistics from Table 1 of Malik (19) were extracted and placed in our Tables 6 and 7. 
Using their Risk Ratios and Confidence Limits we computed z-tests, unadjusted and adjusted p-
values. Note that in our Tables 6 and 7, we have two rows for Nettleton, one for diabetes and one 
for metabolic syndrome. After Bonferroni adjustment, there are no statistically significant 
results, which implies that the observed risk ratios are biased. With the raw data, we could use 
resampling to compute more accurate adjustments, Westfall and Young (32). 
Table 7 gives more characteristics related to statistical testing. We note the number of 
foods used in the food frequency questionnaires, FFQs. The number varies from a low of 61 to a 
high of 165. Each of these foods could be used individually or in combination as a predictor of 
the health effect. The number of covariates given explicitly in Table 2 of Malik (19) is given as 
Total. Note that their counts of covariates are smaller than the number of covariates we counted 
(Table 4). Clearly, the number of covariates mentioned in the abstract (Table 4), is an 
underestimate of the number of covariates in play.  
It is common to group the predictors. In this case, the number of groupings varies from 3 
to 5. Using these groupings, the researchers tested for a linear trend, outcome versus ordered 
group, and they also tested the highest group against the lowest group so there were two dose 
response tests. The number of groupings could be selected to affect the results. Finally, each 
paper presents many reported p-values, #Tests. None of the primary papers reported any 
adjustment for multiple testing or multiple modeling, nor did they point to a registered protocol. 
 
DISCUSSION 
The first point to make is that the authors of the primary papers were, in effect, doing 
exploratory analyses. The analysis search space for each paper was vast and nominal statistical 
significance of 5% is, at best, a screen, not confirmatory in any sense. A major multiple testing 
dilemma occurred in the 1990s when genomics came on line. Lander and Kruglyak (32) argued 
that for claims to be believable there should be multiple testing correction over the entire 
analysis search space. None of the ten primary papers we examined performed any adjustment 
for multiple testing or multiple modeling and that appears to be the norm for analysis of Food 
Frequency Questionnaires, FFQs. By listing multiple outcomes, multiple predictors, and multiple 
covariates, the authors of these ten papers essentially declare their work exploratory. As the 
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authors of the primary studies pointed to no protocol, provided no data, and made no multiplicity 
or modeling adjustments, the reader is left without much recourse other than to consider the 
papers exploratory. 
Two recent books by Harris (34) and Chandler (35) note that multiple testing, which they 
term p-hacking, and justifying a test of hypothesis AFTER looking at the data, HARKing 
(Hypothesizing After the Results are Known) are very common and of course upset the validity 
of p-values and would bias any associated statistics. 
Here is a missing insight.  In real science, a hypothesis is refined and then retested with 
new data on a more restricted question. The protocol is written before the new data is analyzed. 
There is statistical error control. There is often replication. We should give greater credence to 
the results of the new, more definitive study. If it is positive, we say the hypothesis is supported, 
standard Karl Popper reasoning. If the new study fails, we consider abandoning the hypothesis 
and spend science resources on some other problem. 
In FFQ studies there are ~60 to ~130 food questions and many of these food questions 
are repeated from one study to another. If the covariates are fixed in a protocol so they do not 
introduce model variation, then nutrition studies that use FFQs in addition to making claims for 
positive findings, offer an opportunity for replicating findings (or not) from other studies. The 
statistical analysis of each food is easily accomplished with a few lines of code. A p-value plot 
would facilitate examination of all the questions, Schweder and Spjøtvoll (36) as was done in 
Young et al.(37). 
It is rather routine for a researcher not to submit negative papers for publication as the 
belief is that editors are likely to reject negative papers. Informal conversations with multiple 
authors of published negative studies support the difficulty of getting them published. Across the 
board, negative studies have a more difficult time getting published. Given that negative papers 
are typically not published, eventually, we can have serious publication bias, positive studies are 
accepted as they support the current paradigm and negative studies are rejected. As far as we 
know, observational studies used as primary studies in meta-analyses are not routinely examined 
for multiple testing and multiple modeling biases. For more discussion of publication bias see 
Wikipedia (14), Publication bias. 
 Humans like good stories, which becomes a useful art in the writing of a scientific paper. 
Authors can accentuate positive papers and downplay or even omit negative papers, Kabat (38). 
It is very easy for presumptively neutral researchers to become believers in their own claim, 
Feynman (38) among many others, or an existing popular paradigm, e.g. Kuhn (39).  
Kuhn (39) noted that it is very difficult to overturn an existing scientific paradigm. Those 
doing nutrition and health effects research should be held to strict scientific standards: state if a 
study is exploratory, refine claims coming from an exploratory study for a confirmatory study, 
and most importantly, make data sets and analysis code available, etc.  
Scientifically and logically, it is not possible to prove a negative so to make a public 
health claim, an investigator should provide strong evidence - an analysis that names all the 
questions at issue, and fairly adjust for multiple testing and multiple modeling. None of the 
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claims made in the 10 primary papers can be considered reliable due to potential bias, and hence 
they are inappropriate for inclusion in a meta-analysis.  
 
We, the science community, are not recognizing that authors are doing exploratory data 
analysis over and over, year after year. They look at multiple outcomes, multiple causes, any 
number of covariates, and any number of predictors. They try this and try that analysis and 
publish a paper if they get a p-value less than 0.05 where a plausible story can be made (34, 35, 
38). If they fail to find "statistical significance," then it appears that they simply do not publish. 
Those doing meta-analyses need to realize the problem to their work. Authors, editors, and 
consumers can become true believers in a false paradigm. 
 
Finally, the lead author of each of the 10 primary papers was contacted twice asking if 
data used in their paper were available. None of the authors provided their analysis data set. 
Unfortunately, it is common for authors not to provide their analysis data set. Without access to 
the data sets, it is not possible to adjust the analysis for multiple testing and multiple modeling. 
From what is available in the papers and as summarized in Table 1 of Malik (19), it appears that 
none of the claims made in the 10 primary papers would be statistically significant after 
adjustment. The data should be made public so that the analyses can be corrected for the bias 
introduced by multiple testing and multiple modeling. 
 
SUMMARY 
Ten primary papers used in the meta-analysis study by Malik et al. (19) were carefully 
examined with respect to the range of analysis options open to the researcher, and the size of the 
analysis search space. The search space for each paper is large (in many cases vast) considering 
all the questions possible, so that testing claims at a nominal 0.05 is problematic. Meta-analysis 
using these papers should also be considered unreliable until the reliability of the underlying 
primary papers is assessed or confirmatory studies are run. 
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Table 1: Review of Sample Size for 10 Primary papers 
 
Paper ID 
Overall 
Sample 
Size  Sample Size per Group 
Nettleton et al. (2009) 6,814 
Rare or never: 2961, >rare/never but < 1 servings per week: 455, 
>= 1 servings/week to < 1 servings/day: 914, >=1 serving/day: 681 
Lutsey et al. (2008) 9,514 Men: 4197, Women: 5317 
Dhingra et al. (2007) 8,997 
<1 soft drinks per day: 5840, 1 soft drinks per day: 1918, >= 2 soft 
drinks per day: 1239 
Montonen et al. (2007) 4,304 
 1st quartiles: 1076, 2nd quartile: 1076, 3rd quartile: 1076, 4th 
quartile: 1076 
Paynter et al. (2006) 12,204 Men: 5414, Women: 6790 
Schulze et al. (2004) 91,249 
For 1991, <1/mo: 49203, 1-4/mo: 23398, 2-6/wk: 9950, <1/d: 8698; 
For 1991-1995, <=1/wk: 38737, >=1/d: 2366, <=1/wk to >=1/d: 
1007, >=1/d tp <=1/wk: 1020 
Palmer et al. (2008) 43,960 
Soft drinks per week: <1: 25971, 2-6: 10521, >=1: 7468; Fruit 
Drinks per Week : <1: 15455, 2-6: 13722, >=1: 13644 
Bazzano et al. (2008) 71,346 
quintile 1: 14573, quintile 2: 14408, , quintile 3: 14337, , quintile 4: 
14118, , quintile 5: 13913 
Odegaard et al. (2010) 43,580 
Soft drink consumption: almost never: 32060, 1-3/Month: 4514, 
1/week: 2389, 2-3/week: 4617; Juice Consumption: almost never: 
35719, 1-3/Month: 4399, 1/week: 1791, 2-3/week: 1671 
De Koning et al. (2010) 40,389 
Sugar Sweetened beverages: Q1: 13675, Q2: 5022, Q3: 11729, Q4: 
9963; Artificially sweetened beverages: Q1: 18442,  Q2: 2681, Q3: 
9448, Q4: 9818 
Across all articles 332,357 Number of Groups: 2,2,3,(3,3),4,(4,4),(4,4),(4,4),5  
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Table 2: P-values, Relative Risks, Multiplicity Adjustment & Funding Source for 10 Primary 
papers 
Paper ID 
Smallest 
p-value 
Largest RR 
(Hazard 
ratio) 
Largest 
RR: CI 
Multiplicity 
Adjustment 
for p-values Funding Source 
Nettleton et al. 
(2009) <0.001 2.2 (1.1-4.51) 
 
 
No Government 
 
Lutsey et al. 
(2008) <0.001 1.34 (1.24-1.44) 
 
 
No Government 
Dhingra et al. 
(2007) <0.0001 2.31 (1.77-3.01) 
 
 
No 
 
Government and 
Non-government 
Montonen et al. 
(2007) <0.001 5.06 (1.87-3.71) 
 
 
No Unfunded 
Paynter et al. 
(2006) <0.01 1.23 (0.93-1.62) 
 
 
No Government 
 
Schulze et al. 
(2004) <0.001 2.31 (1.55-3.45) 
 
 
No Government 
 
Palmer et al. 
(2008) 0.001 1.51 (1.31-1.75) 
 
 
No Government 
 
Bazzano et al. 
(2008) <0.001 4.47 (2.35-7.66) 
 
 
No Government 
Odegaard et al. 
(2010) <0.0001 1.7 (1.34-2.16) 
 
 
No Government 
De Koning et al. 
(2010) <0.01 1.94 (1.75-2.14) 
 
 
No Government 
Across all 
articles 
<0.0001 
- <0.01 1.23 - 5.06  
 
90% Government 
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Table 3: Search space Size of 10 Primary papers based on Abstracts 
Primary papers Primary papers 
Journals 
Outcomes Predictors Covariates Space Size 
Nettleton et al. Diabetes Care 2009 2 1 3 24 
Lutsey et al. Circulation 2008 1 2 4 32 
Dhingra et al. Circulation 2007 7 1 10 7,168 
Montonen et al. J Nutr 2007 1 5 0 5 
Paynter et al. Am J Epidem 2006 1 2 0 2 
Schulze et al. JAMA 2004 2 1 2 8 
Palmer et al. Arch Intern Med 2008 1 1 2 4 
Bazzano et al. Diabetes Care 2008 1 3 0 3 
Odegaard et al. Am J Epidem 2010 1 2 2 8 
de Koning Am J Epidem 2011 1 3 10 12,288 
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Table 4:  Space Size of 10 Primary papers based on Texts of Papers 
Primary papers Primary papers 
Journals 
Outcomes Predictors Covariates Space Size 
Nettleton et al. Diabetes Care 2009 2 2 15 196,608 
Lutsey et al. Circulation 2008 1 2 14 32,678 
Dhingra et al. Circulation 2007 7 1 24 117,117,952 
Montonen et al. J Nutr 2007 1 12 15 392,396 
Paynter et al. Am J Epidem 2006 1 2 14 32,678 
Schulze et al. JAMA 2004 2 3 9 (Mod 1) 3,072 
Palmer et al. Arch Intern Med 2008 2 3 15 196,608 
Bazzano et al. Diabetes Care 2008 1 5 13 40,960 
Odegaard et al. Am J Epidem 2010 2 2 16 262,144 
de Koning Am J Epidem 2011 1 3 24 6,291,456 
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Table 5:  Sample size, Expected value of largest Order Statistics and corresponding P-Values. 
Note that the value of the largest order statistics for N of 1000 and 5000 was computed using a 
formula of Blom (1958). 
 
N Exp. Value of largest Order Statistic P-Value 
10 1.53875 0.12211 
20 1.86748 0.06976 
30 2.04276 0.04952 
40 2.16078 0.03864 
50 2.24907 0.03181 
60 2.31928 0.02709 
70 2.37736 0.02364 
80 2.42677 0.02099 
90 2.46970 0.01890 
100 2.50759 0.01720 
125 2.58634 0.01407 
150 2.64925 0.01194 
175 2.70148 0.01038 
200 2.74604 0.00919 
225 2.78485 0.00826 
250 2.81918 0.00750 
300 2.87777 0.00635 
350 2.92651 0.00551 
400 2.96818 0.00487 
1000 3.24144 0.00119 
5000 3.67755 0.00024 
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Table 6: Risk Ratios, Confidence Limits taken from Table 1 of Malik et al. 2010.  Z-tests, p-
values, adjustment factors and adjusted p-values were computed. 
Ref Sig RR CLL CLH Beta BetaSE Z Prob AdjFactor AdjP 
Nettleton 
et al. 
0.05 0.86 0.62 1.17 -0.151 0.162 -0.931 0.8241 116736 1.000 
Lutsey et 
al. 
p-
val 
1.09 0.99 1.19 0.086 0.047 1.836 0.0332 540672 1.000 
Dhingra et 
al. 
CL 
95% 
1.39 1.21 1.59 0.329 0.070 4.726 <0.0001 244 0.000 
Montonen 
et al. 
CL 
95% 
1.67 0.98 2.87 0.513 0.274 1.871 0.0307 102400 1.000 
Paynter et 
al. 
CL 
95% 
1.17 0.92 1.39 0.122 0.157 1.491 0.0679 244 1.000 
Schulze et 
al. 
0.05 1.83 1.42 2.36 0.604 0.130 4.663 <0.0001 2179072 1.000 
Palmer et 
al. 
CL 
95% 
1.24 1.06 1.45 0.215 0.080 2.692 0.0036 2228224 1.000 
Bazzano 
et al. 
CL 
95% 
1.31 0.99 1.74 0.270 0.144 1.877 0.0303 11264 1.000 
Odegaard 
et al. 
CL 
95% 
1.42 1.25 1.62 0.351 0.066 5.301 <0.0001 1351680 0.078 
de Koning 0.05 1.14 1.03 1.28 0.131 0.055 2.364 0.0090 8384 1.000 
Nettleton 
et al.* 
0.05 1.15 0.92 1.42 0.140 0.111 1.262 0.1034 116736 1.000 
 
*This was not included in the pool of ten primary papers that but was reported by Malik. Et al 
(2010). 
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Table 7: Number of foods, FFQ, considered in each primary paper, the Total number of 
covariates. TCovars, the number of groupings used for predictors and the type of statistical 
testing – based on Table 1 of Malik. Also given are the number of p-values reported, #Tests, 
derived by counting in each primary paper. 
Ref FFQ TCovars #groups Method #Tests 
Nettleton * 114 10 4 Trend, Each vs control 88 
Lutsey  66 13 5 Trend, Each vs control 85 
Dhingra  61 2 3 Trend, Each vs control 101 
Montonen  100 10 4 Trend, Each vs control 63 
Paynter  61 2 5 Trend, Each vs control 60 
Schulze  133 14 4 Trend, Each vs control 54 
Palmer  68 15 3 Trend, Each vs control 87 
Bazzano  88 7 5 Trend, Each vs control 114 
Odegaard  165 13 4 Trend, Each vs control 50 
de Koning 131 6 4 Trend, Each vs control 84 
 
*This was not included in the pool of ten primary papers but was reported by Malik, et al (19). 
His references are given as our references (20-29). 
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Appendix: Protocol V02: MMA Study 
Note: Sections of Protocol V01 were rewritten upon discovering that the Malik et al paper had 
only 10 non-overlapping primary papers. 
Co-PI: Karl Peace, Jiann-Ping Hsu College of Public Health, Georgia Southern University, 
kepeace@georgiasouthern.edu 
Co-PI: Stan Young, CGStat, genetree@bellsouth.net  
Background: For many nutritional questions randomized trials are not available so 
observational studies are conducted. It is common to gather a number of observational studies 
related to a question. The individual studies are evaluated and summary results from the studies 
are combined using what is called meta-analysis methods. 
Idea: Our study is to evaluate the reliability of a nutritional meta-analysis study by examining 
the statistical reliability of the underlying studies. 
The meta-analysis study of Malik, et al. (19) was selected for study. Within the paper there 
appeared to be 11 cited base studies. However, upon examination of Dr. Young, one appeared a 
replicate. Hence only the 10 non-overlapping primary papers were reviewed and contained data 
for extraction. 
Objectives:  
a. Determine the size of the analysis search space for each observational base study of a 
meta-analysis. 
b. Determine if uncorrected summary statistics invalidate meta-analysis claims. 
Study Population: Primary papers from a meta-analysis paper of observational studies. 
Locating studies: Reference list from the meta-analysis paper 
Screening and Evaluation Methods:  
a. Read meta-analysis and primary papers. 
b. Fill in Data Extraction Form 
c. Ask for data access. 
Operation:  
Two teams will be formed, each consisting of an Assistant Professor of Biostatistics, a DrPH 
student and a Master's level student.  Membership of the teams will be determined randomly.  
The 10 primary papers will be randomly assigned in balanced fashion to the two teams.  Each 
team will review and extract data from the assigned 5 papers during period 1. The 5 papers 
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reviewed by Team 1 will then be crossed over to Team 2 for review and data extraction and vice 
versa. Differences in extraction results between the two teams will be resolved by the Co-PIs. A 
final Data Extraction Form will be completed for each paper. All Data Extraction Forms will be 
posted to the study folder on the Google drive in PDF format. 
The search space will be computed for each primary paper as: 
#outcomes x #predictors x 2c,  where c is the number of covariates in the final model. 
Results: The summary results for a paper will be considered unreliable if the search space is 
greater than 100 or if #outcomes x #predictors is greater than 10. The meta-analysis paper will be 
considered unreliable if over ¼ if the primary papers are considered unreliable. 
References: 
To minimize print space, the Malik et al paper is reference 19 and the 10 primary papers are 
references 20-29 of the References section of the manuscript. 
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Data Extraction Form         Preliminary    Final 
MMA Study: Malik et al. Diabetes Care 2010; 33, 2477-2483. 
Your name________________________    Date_________________ 
1. Paper (fill in the literature references as it appears in the meta-analysis paper) 
2. PI: name, email address, regular mail 
3. Journal editor: name, email address 
4A. Overall Sample size: ______________ 
4.B  Sample size per Group (identify group) 
       Group 1: ________________________  Sample Size____________ 
       Group 2: ________________________  Sample Size____________ 
       Group 3: ________________________  Sample Size____________ 
       Group 4: ________________________  Sample Size____________ 
5. Smallest p-value _________    Largest RR with CL _________________ 
6. # outcomes          From Abstract_____       From Paper_____ 
7. # predictors          From Abstract_____       From Paper_____ 
8. # covariates          From Abstract_____       From Paper_____ 
8.A. #  potential covariates mentioned ______________ 
8.B. # Covariates used in the analysis model ______________ 
9. Is a food questionnaire used in the study?  Yes   No 
10. Raw Data available (as stated in the paper)?  Yes   No 
11. Funding source.  Government Grant Number________    Industry______    Unfunded    
12. Eligibility Criteria 
 
13. Comments. Any other things of potential interest noted while reviewing the paper. 
